Choptank Community Health System’s dental practice recently welcomed Andrés Álvarez-Deal and Megan Patterson Poteat to its Cambridge Dental Center and David Martin to its Federalsburg Dental Center.
Part A of the Phase 2 study ANAVEX ® 3-71-SZ-001 ( NCT06245213 ), was a multiple ascending dose study in 16 participants treated with either oral placebo, oral ANAVEX ® 3-71 90 mg daily, or oral ...